Global Market Quick Take: Asia – August 8, 2023 Global Market Quick Take: Asia – August 8, 2023 Global Market Quick Take: Asia – August 8, 2023

Global Market Quick Take: Asia – August 8, 2023

Macro 6 minutes to read
APAC Research

Summary:  US equities rebounded as the S&P 500 and Nasdaq both gained 0.9%. Tesla initially fell over 4% due to its CFO's departure but recovered to losing 1%. Berkshire Hathaway surged 3.6%, driven by strong Q2 earnings. Hong Kong indices traded flat, with pharmaceutical stocks sliding due to Chinese anti-corruption efforts. The yen faced pressure as US long-end yields rose, while US used car prices slumped in July, reducing inflationary pressure. Japan saw slowed wage growth. Moody's downgraded some US regional banks. China's export contraction is predicted to worsen in July.


What’s happening in markets?

US equities (US500.I and USNAS100.I): Stocks rebound as S&P 500 and Nasdaq recover; Berkshire Hathaway surges

Stocks rebounded on Monday, recovering from the sharp decline in the previous week. Both the S&P 500 Index and the Nasdaq 100 Index showed resilience by registering gains of 0.9%, reaching 4,518 and 15,407, respectively. As news headlines were quiet and over 80% of the S&P500 constituents had reported Q2 results, investors tended to sideline, waiting for the CPI data this Thursday.

Tesla (TSLA:xnas) had a notable intraday swing, initially experiencing a loss of over 4% following the departure of its CFO. However, the stock managed to pare some of these losses and settled 1% lower. Meanwhile, Berkshire Hathaway (BRKb”:xnys) gained 3.6%. This surge propelled the company's stock past its previous high set in March 2022. The strong performance was attributed to Berkshire Hathaway's Q2 earnings, which surpassed estimates, primarily driven by the robust performance of its insurance segment.

Treasuries (TLT:xnas, IEF:xnas, SHY:xnas): bear steepens ahead of the refunding

While the 2-year notes finished Monday nearly unchanged, the rest of the yield curve sold off, with yield rising under renewed bear-steepening pressure ahead of large supply from the USD103 billion refunding auctions, plus corporate issuance this week. Kicking of the refunding today is USD42 billion 3-year notes. The 10-year yield rose 5bps to 4.09%, narrowing the 2-10-year spread to -67.

Hong Kong & Chinese equities (HK50.I & 02846:xhkg): Hong Kong indices trade flat amidst low volume; pharmaceutical stocks slide

Major Hong Kong indices traded sideways with the lowest volume in nearly two weeks. The Hang Seng Index, Hang Seng China Enterprises Index, and Hang Seng Tech Index all ended the session unchanged. Southbound mainland flows amounted to a net purchase of HKD4.4 billion. Leading the gainers were food and beverage stocks, with Haidilao (06862:xhkg) surging 4.9% and Budweiser (01876:xhkg) rising 3.7%. Riding the strong uptrend in crude oil prices, CNOOC (00883:xhkg) added 2.6% and PetroChina (00857:xhkg) gained 1.8%.

Pharmaceutical shares saw the most significant losses on Monday, extending the decline from the previous week due to investor retreat following increased Chinese authorities' anti-corruption efforts in the industry. Hansoh Pharmaceutical (03692:xhkg) suffered a 10% drop. Country Garden (02007:xhkg) and Country Garden Services (06098:xhkg) plunged more than 7%, driven by concerns about the property group's liquidity. Similarly, in the A-share market, pharmaceuticals and property led the losses, contributing to a 0.8% decline in the CSI300. In terms of northbound flows, there was a net sale of RMB2.5 billion.

FX: Yen under pressure as long-end yields continue to climb

Large funding auction kept the long-end of the US yield curve under pressure and that saw yen being the G10 underperformer once again. USDJPY rose back above 142.40 from lows of 141.52 with focus on US CPI this week to gauge how far Treasury yields could go. GBPUSD was back higher to test the 1.28 handle with BOE likely remaining as the last hiker in the G7 pack. BoE Pill, in a Q&A, said inflation remains much too high and he has seen a lot of news on inflation persistence, but caveated that there is risks on both sides on UK inflation. Pill warned there are risks the UK hasn't raised rates enough.

Crude oil: weighed by the risk off tone

While crude oil market remains underpinned by ongoing supply concerns, the risk off sentiment overnight weighed on oil prices. Crude oil prices however rebounded in the Asian morning as focus turned to EIA’s short-term energy outlook due later today. Traders are also bracing for the CPI release on Thursday and focus is also on China data that starts to kick in from today with July exports.

Gold: plunged on rising yields

As long-end Treasury yields continue to climb, gold is coming under pressure. XAUUSD dropped from $1945 to lows of $1931 before finding support. Holdings in bullion backed exchange traded funds have also been falling and are at their lowest level in more than three years. However, central bank buying remains strong. China’s central bank added to its gold reserves for the ninth straight month in July. Total stockpiles now sit at 2,137t, with around 188t added since purchases began in November.

 

What to consider?

US used car prices slumped in July

US used vehicle prices decreased by 1.6% MoM in July to the lowest levels since April 2021, and registered a decline of 11.6% YoY. With a weight of 2.7% in CPI, the sustained decline in used car prices continues to push downward pressure on inflation due this week. However, it is worth noting that price declines are slowing month after month, and suggests that the pace of slowdown in inflation may moderate as well.

Slowing monthly earnings and spending in Japan

Japan’s wage growth slowed in June with nominal wages rising 2.3% YoY from 2.9% YoY in May while real wage growth saw a sharper contraction of 1.6% YoY from -0.9% YoY previously. Household spending, meanwhile, slumped by 4.2% YoY in June from -4.0% YoY in the previous month. The deeper decline in real earnings may weigh on consumption and puts more weight on the BOJ’s case that inflation is supply-driven. This continues to make a case for the Bank of Japan to continue with its easy monetary policy.

Moody’s downgrades 10 US regional banks and puts Bank of NY Mellon, US Bancorp, Northern Trust, and Truist Financial under review for downgrade

Moody’s announced to downgrade 10 US regional banks, including M&T, Amarillo National Bank, Old National Bancorp, Commerce Bank, Associated Banc-Corp, BOK Financial Corporation,  Webster Bank, Prosperity Bank, Fulton Bank, and Pinnacle Financial Partners. Additionally, Moody’s put Bank of New York Mellon, US Bancorp, Northern Trust, and Truist Financial under review for downgrade. Moody’s said the rationale for the actions is to reflect the ongoing strain in the US banking sector, including increased funding pressures and potential regulatory capital weaknesses. For some of these banks, Moody’s also cited rising risks associated with commercial real estate exposures as an additional reason for the actions. 

China's export contraction is expected to deepen in July

The median forecast from economists regarding China's export growth in USD terms is a contraction of 13.2% Y/Y for July. This decline is more pronounced when compared to the 12.4% drop observed in June. The export sector might face headwinds due to the ongoing global manufacturing slowdown and the restrictions on China's access to high-end chips. Conversely, import growth in USD terms is anticipated to show a minor improvement, with a Y/Y decline of -5.6% projected for July, as compared to the -6.8% decline witnessed in June. Nonetheless, this anticipated uptick may be attributed to elevated commodity prices rather than a smaller contraction in volume.

 

 

For a detailed look at what to watch in markets this week – read our Saxo Spotlight.

For a global look at markets – tune into our Podcast.

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.